Press release
Global Bevacizumab Biosimilars Market 2024 - By Size, Drivers, Trends, Competitors And Forecast To 2033
Global Bevacizumab Biosimilars Market
Bevacizumab Biosimilars Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.09 billion In 2028 At A CAGR Of 7.8% :
The bevacizumab biosimilars market size has grown strongly in recent years. It will grow from $1.43 billion in 2023 to $1.55 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to patent expiry, cost containment in healthcare, increasing incidence of cancer, market competitiveness, patient access and affordability, biosimilar acceptance.
The bevacizumab biosimilars market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising demand for cancer therapies, biosimilar development expertise, healthcare system pressures, biosimilar regulatory landscape, biosimilar interchangeability. Major trends in the forecast period include collaborations and partnerships, regulatory advancements and approvals, biosimilar development and innovation, market access strategies, biosimilar lifecycle management.
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=10848&type=smp
Bevacizumab Biosimilars Market Major Segments
The bevacizumab biosimilars market covered in this report is segmented -
1) By Product: Avastin, Mvasi, Zirabev, Aybintio, Other Products
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Colorectal Cancer, Non-small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Cervical Cancer, Ovarian Cancer
Key Driver - Growing Cancer Prevalence Fuels Bevacizumab Biosimilars Market Expansion
The rising prevalence of cancer cases is expected to propel the growth of the bevacizumab biosimilars market going forward. Cancer incidence refers to the number of new cancer cases in a specific population for a given period. Bevacizumab is a biologic that inhibits tumor angiogenesis, which can lead to tumor shrinkage and growth inhibition, and it is comparable to reference biologics in terms of efficacy and safety in treating patients with advanced non-small cell lung cancer or metastatic colorectal cancer. For instance, in October 2022, according to reports published by Macmillan Cancer Support, a UK-based health care charity organization, it was anticipated that there were 3 million cancer patients in 2020, with that figure expected to climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising prevalence of cancer cases drives the bevacizumab biosimilars market.
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=10848&type=smp
Prominent Trend - Advancing Product Innovation In Bevacizumab Biosimilars Market
Product innovation has emerged as a key trend gaining popularity in the bevacizumab biosimilars market. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2022, Viatris, a US-based pharmaceutical company, and Biocon Biologics, a US-based pharmaceutical company, launched a biosimilar called Abevmy (bevacizumab), which is a biosimilar like Roche's Avastin (bevacizumab). Abevmy has received approval from Health Canada for use across four oncology indications. The product offers efficacy, safety, and quality like the reference biologic, as it is a synthesized humanized monoclonal antibody (MA) that binds to and neutralizes the biologic action of human vascular endothelial growth factor (VEGF).
Bevacizumab Biosimilars Market Players
Major companies operating in the bevacizumab biosimilars market report are Cipla Limited, Reliance lifesciences Pvt. Ltd., Genentech Inc, Fujifilm Kyowa Kirin Biologics Co. Ltd., Pfizer Inc., Abbvie Inc., Amgen Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Mylan Inc., Daiichi Sankyo Company Limited, Beaconpharma Ltd., Innovent Biologics Inc., STADA Arzneimittel AG, Shanghai Henlius Biotech Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Intas Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Samsung Bioepis Co. Ltd., Celltrion Inc., Coherus BioSciences Inc., Hetero Drugs Ltd., EirGen Pharma Ltd., Allergan Plc., Apotex Inc., BioXpress Therapeutics SA, Celgene Corporation Co. Ltd., mAbxience SA
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/bevacizumab-biosimilars-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the bevacizumab biosimilars market in 2023. The regions covered in the bevacizumab biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Bevacizumab Biosimilars Market Report Structure
3. Bevacizumab Biosimilars Market Trends And Strategies
4. Bevacizumab Biosimilars Market - Macro Economic Scenario
5. Bevacizumab Biosimilars Market Size And Growth
…..
27. Bevacizumab Biosimilars Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Bevacizumab Biosimilars Market 2024 - By Size, Drivers, Trends, Competitors And Forecast To 2033 here
News-ID: 3510953 • Views: …
More Releases from The Business research company
Server Operating System Market Report 2024-2033: Size, Share, Growth, Trends, An …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Server Operating System Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $110.27 billion In…
Safety Light Curtain Market Report 2024-2033: Size, Share, Growth, Trends, Analy …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Safety Light Curtain Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.41 billion In…
Regenerated Cellulose Market Report 2024-2033: Size, Share, Growth, Trends, Anal …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Regenerated Cellulose Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $23.15 billion In 2028…
Propanol Market Report 2024-2033: Size, Share, Growth, Trends, Analysis, Outlook …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Propanol Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $47.08 billion In 2028 At A…
More Releases for Bevacizumab
2020-2025: Bevacizumab Biosimilar Market Report Covers Growing Strategies Used B …
Business Industry Reports Research has recently announced a report on Global Bevacizumab Biosimilar Market based on the Healthcare Industry. The Bevacizumab Biosimilar Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2025.
Global Bevacizumab Biosimilar Market overview:
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are…
Global Bevacizumab Market Research Report
This report studies the global Bevacizumab market status and forecast, categorizes the global Bevacizumab market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Genentech Allergan Hetero Drugs Reliance Life Science Geographically, this report studies the top producers and consumers, focuses on product…
Bevacizumab Biosimilar Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/bevacizumab-biosimilar-market-2/71809
The global market size of Bevacizumab Biosimilar is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand, major…
Global Bevacizumab Biosimilar Market Insights, Trends, Growth, Size, Segmentatio …
A newly compiled business intelligent report, titled “Global Bevacizumab Biosimilar Market Insights, Forecast to 2025” has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of (Bevacizumab Biosimilar) market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360 view on current…
Bevacizumab Market to Witness Widespread Expansion by 2025
Cancer is a disease which involves uncontrolled cell growth which also has potential to metastasize/spread to other parts of the body. Cancer can be malignant or benign. Benign tumors generally do not spread to other parts of the body. Malignant tumors metastasize to the other parts of the body. Usual signs and symptoms of cancer are change in bowel movements, abnormal bleeding, unexplained weight loss, prolonged cough etc. Cancer is…
Global Bevacizumab Sales Market Analysis, Assessment & Forecast Growth, 2017 – …
A new report focusing on the consumer credit card market has been announced to the Market Research Hub’s collection of research database. The report is titled as “Global Consumer Credit Market 2016-2020”, provides an in-depth analysis with inputs from industry experts. The report holistic outlook of the market, covering its growth prospects and market landscape over the coming years. As per the research key findings, the global market for consumer…
